Last reviewed · How we verify
NCT05104827
Integrative Medicine Impact on Frontline COVID-19 Personnel Wellbeing
NA trial testing Complementary Integrative Medicine in Wellbeing of Healthcare Providersin Frontline COVID-19 Departments in 300 participants. Completed in 1 June 2024.
31 December 2023
Quick facts
| Lead sponsor | Carmel Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 300 |
| Start date | 31 December 2020 |
| Primary completion | 31 December 2023 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Complementary Integrative Medicine
Conditions studied
- Wellbeing of Healthcare Providersin Frontline COVID-19 Departments — all drugs for Wellbeing of Healthcare Providersin Frontline COVID-19 Departments →
Sponsor
Carmel Medical Center
Who can join
18 and older, any sex, with Wellbeing of Healthcare Providersin Frontline COVID-19 Departments. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Treating COVID-19 hospitalized patients incurred heavy burden of physical and emotional stress. The present study is taking place at Carmel Medical Center in collaboration with the integrative oncology and the internal medicine teams with aim to improve the wellbeing of healthcare providers working in frontline COVID-19 departments. In this prospective preference study, Healthcare providers (HCPs) working inside COVID-19 departments are referred to integrative oncology-trained practitioners for assessment of their two leading concerns followed by 30-minute individually tailored treatment. The study assess, based on the Measure Yourself Concerns and Wellbeing (MYCAW) questionnaire, the impact of personalized integrative oncology modalities on the physical and emotional concerns as well as Heart Rate Variability of participating HCPs in COVID-19 departments.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Parasympathetic Versus Sympathetic Changes in Heart Rate Variability After a Multimodal Integrative Medicine Intervention for Frontline COVID-19 Personnel.
Vagedes J, Kassem S, Gressel O, Samuels N, et al · · 2023 · cited 5× · PMID 36346679 · DOI 10.1097/psy.0000000000001153
Verify or expand the search:
- PubMed search for NCT05104827
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Carmel Medical Center trials
Trials by the same sponsor.
- NCT06604455 — Impact of Acupuncture and Integrative Medicine on Patients Quality-of-life During National Emergency and Wartime · NA · recruiting
- NCT06612749 — Assessing the Impact of Integrative Medicine on Anxiety and Wellbeing of Healthcare Providers Exposed to Terror or War · NA · recruiting
- NCT06598020 — Evaluating the Impact of an Integrative Oncology Training Program for Healthcare Providers · NA · active not recruiting
- NCT06590766 — Impact of Acupuncture and Manual Therapies on Patients' Quality-of-life in a Hospital-to-community Continuum · NA · recruiting
- NCT06167057 — POST URS Chemotherapy Instillation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05104827 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carmel Medical Center
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05104827.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing